Fresenius SE & Co KGaA operates within the Kidney dialysis centers sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fresenius SE & Co KGaA with three other
health care providers in North America:
Fresenius Medical Care AG & Co. KGaA
sales of $19.50 billion
of which 70%
was North America),
Tenet Healthcare Corporation
of which 83%
was Hospital operations and other), and
HCA Healthcare Inc
of which 100%
was Health Care).
During the year ended December of 2018, sales at
Fresenius SE & Co KGaA were $39.51 billion.
increase of 2.3%
versus 2017, when the company's sales were $38.60 billion.
This was the third consecutive year of growth at Fresenius SE & Co KGaA.
Sales of Fresenius Vamed saw an increase
that was more than double the company's growth rate: sales were up
35.8% in 2018, from
$1.34 billion to $1.82 billion.
Fresenius SE & Co KGaA also saw significant increases in sales in
Fresenius Helios (up 7.4% to $10.58 billion)
Fresenius Kabi (up 6.5% to $7.65 billion)
Not all segments of Fresenius SE & Co KGaA experienced an increase in sales in 2018:
sales of Corporate/other fell 58.6% to $2.36 million.
(However, this segment's sales were only a very small portion of the company's overall sales).
Fresenius SE & Co KGaA also experienced decreases in sales in
Fresenius Medical Care (down 3.8% to $19.46 billion)